ProCE Banner Activity

ART Safety and Tolerability: Questions, Answers, and More Questions

Clinical Thought
Data from 2020 conferences have shed new light on the issues of ARV-associated weight gain and ART safety during conception and pregnancy. Here are expert answers to your outstanding questions.

Released: December 07, 2020

Expiration: December 06, 2021

No longer available for credit.

Share

Faculty

Danielle Roman

Danielle Roman, PharmD, BCOP

Manager, Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania

Brian Wood

Brian Wood, MD

Assistant Professor of Medicine
Division of Allergy and Infectious Disease
University of Washington
Seattle, Washington

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by an educational grant from

Janssen Therapeutics Division of Janssen Products

Faculty Disclosure

Primary Author

Danielle Roman, PharmD, BCOP

Manager, Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania

Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Atea, GlaxoSmithKline, Gilead Sciences, Merck, and ViiV and funds for research support from Atea, Gilead Sciences, Merck, Novartis, and ViiV.

Brian Wood, MD

Assistant Professor of Medicine
Division of Allergy and Infectious Disease
University of Washington
Seattle, Washington

Brian Wood, MD, has no relevant conflicts of interest to report.